V.P. BUSINESS DEVELOPMENT, TRIANNI INC.
San Francisco, CA, California, United States
Dr. Masat is V.P., Business Development for Trianni Inc., a company that has generated a gene-targeted mouse with the full human antibody repertoire. Dr. Masat has 20 years of experience discovering and developing therapeutic antibodies within global biotechnology and biopharmaceutical companies. Most recently, she was Director, Strategic Academic Alliances at Takeda Pharmaceutical, where she established and led collaborations with academic laboratories and early stage companies. Prior to this role, she led multidisciplinary teams at Takeda, XOMA and Abgenix (now Amgen) in the discovery of therapeutic-grade biologics to over 100 targets. Dr. Masat received her Ph.D. in Biochemistry from the University of Urbino, Italy, and did her postdoctoral training at the University of California, San Francisco.